Global Information
회사소개 | 문의

세계의 마이크로플루이딕스 시장 예측 : 재료별, 컴포넌트별(마이크로플루이딕스 칩, 펌프, 니들), 용도별

Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022

리서치사 RNCOS E-Services Pvt. Ltd.
발행일 2018년 09월 상품 코드 486151
페이지 정보 영문 90 Pages
가격
US $ 1,600 ₩ 1,824,000 PDF by E-mail (Single User License)
US $ 1,800 ₩ 2,052,000 CD-ROM
US $ 1,800 ₩ 2,052,000 Hard Copy
US $ 2,700 ₩ 3,079,000 PDF by E-mail (Multi-User License)


세계의 마이크로플루이딕스 시장 예측 : 재료별, 컴포넌트별(마이크로플루이딕스 칩, 펌프, 니들), 용도별 Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022
발행일 : 2018년 09월 페이지 정보 : 영문 90 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 마이크로플루이딕스(Microfluidics, 미세유체 기술) 시장에 대해 분석했으며, 기술·제품 개요, 시장의 기본 구조·최신 상황, 주요 시장 성장 촉진·억제요인, 시장 규모 동향 전망(통산 6년간), 재료별·컴포넌트별·용도별·지역별 동향, 향후 자본 거래·시장 성장 기회, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 애널리스트의 견해

제2장 분석 방법

제3장 마이크로플루이딕스(미세유체 기술) : 개요

제4장 마이크로플루이딕스 시장 개요

  • 마이크로플루이딕스 시장
  • 헬스케어용 마이크로플루이딕스 시장

제5장 시장 성장 촉진요인과 해결해야 할 과제

  • 시장 성장 촉진요인
  • 해결해야 할 과제

제6장 시장 세분화

  • 재료별
    • 세라믹제
    • 폴리머제
    • 기타
  • 컴포넌트별
    • 마이크로플루이딕스용 칩 시장
    • 마이크로플루이딕스용 펌프 시장
    • 마이크로플루이딕스용 니들 시장
    • 기타
  • 용도별
    • 체외(IV) 진단
    • 약제/생명과학 연구
    • 약물 전단
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양 지역
    • 기타 국가(RoW)

제7장 규제 시나리오

  • 북미(미국 등)
  • 유럽
  • 아시아태평양 지역(인도, 중국)

제8장 시장 동향과 발전

  • 마이크로플루이딕스 연구에 대한 조성금 교부 발표
  • 기업 인수합병(M&A)

제9장 기업 평가

KSM 17.05.17

Microfluidics is the science and technology discipline of controlling fluids, usually in the range of microliters to picolitres, in networks of channels with lowest dimensions. The report "Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022" studies the market for the application of microfluidics in pharmaceutical, in-vitro diagnostics, and drug delivery devices. The market is anticipated to grow at a robust CAGR during the forecasted period, i.e. 2017-2022. This growth is likely to be driven by the rising demand for point-of-care devices, quick return on investments provided by microfluidics devices resulting in cost reductions, and miniaturization of microfluidic chips.

On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector. Other major factors such as tough incorporation of emerging microfluidic technologies into existing workflows, and complex and time consuming regulatory standards are hampering the growth of microfluidics market.

According to analysis, the market for microfluidic devices all over the world was worth US$ 3.6 Billion in 2017, and is poised for a double digit growth during the forecasted period (2017-2022). The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; by components, such as microfluidic chips, pumps, and needles; by application, and territory. The In-Vitro diagnostics segment commands the largest share of the global microfluidics applications market. The large share of this segment is attributed to the increasing adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic companies, such as Roche, Becton Dickinson and Company, Abbott, and Cepheid amongst others. Similarly, in microfluidics by components segment, microfluidic chips accounted for the largest share. This large share is attributed to increasing usage of these chips in IVD application.

Based on material, in 2017, ceramics contributed the major share in microfluidics market. This high share is attributed to high chemical resistivity, versatility, and strength offered by ceramics in manufacturing of microfluidics devices.

Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2017. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.

In addition, this study also covers latest trends and developments capturing the market since last few years. The report also includes the regulatory scenario in various countries across the globe.

The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott, etc. Finally, the report covers strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors and debut makers to design relevant business strategies to target the billion dollar market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Microfluidics - An Introduction

4. Microfluidics Market Overview

  • 4.1 Microfluidics Market
  • 4.2 Healthcare Microfluidics Market

5. Drivers & Challenges

  • 5.1 Drivers
    • 5.1.1 Rising Incidence of Chronic Diseases
    • 5.1.2 Increasing Demand of Point of Care Diagnostics
    • 5.1.3 Rising Application in Life Sciences Research
    • 5.1.4 Benefits of Miniaturization of Chip
  • 5.2 Challenges
    • 5.2.1 Manufacturing Difficulties & High Cost of Lab-on Chips Instruments
    • 5.2.2 Ambiguous Regulatory Framework
    • 5.2.3 Lack of Awareness in Emerging Markets

6. Market Segmentation

  • 6.1 By Material
    • 6.1.1 Ceramics
    • 6.1.2 Polymers
    • 6.1.3 Others
  • 6.2 By Components
    • 6.2.1 Microfluidics Chips Based Microfluidic Devices
    • 6.2.2 Microfluidics Pumps Based Microfluidic Devices
    • 6.2.3 Microfluidics Needles Based Microfluidic Devices
    • 6.2.4 Others
  • 6.3 By Applications
    • 6.3.1 In-Vitro Diagnostics
    • 6.3.2 Pharmaceutical & Life Sciences Research
    • 6.3.3 Drug Delivery
    • 6.3.4 Others
  • 6.4 By Geography
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Rest of World

7. Regulatory Scenario

  • 7.1 US
  • 7.2 Europe
  • 7.3 Asia-Pacific
    • 7.3.1 India
    • 7.3.2 China

8. Trends & Developments

  • 8.1 Grants Announced for Microfluidics Research
  • 8.2 Mergers & Acquisitions

9. Competitive Assessment

  • 9.1 Fluidigm Corporation
  • 9.2 F. Hoffmann-La Roche Ltd.
  • 9.3 Bio-Rad Laboratories, Inc.
  • 9.4 Thermo Fisher Scientific, Inc.
  • 9.5 Agilent Technologies, Inc.
  • 9.6 Perkin Elmer, Inc.
  • 9.7 Illumina, Inc.
  • 9.8 Shimadzu Corporation
  • 9.9 Danaher Corporation
  • 9.10 Abbott

List of Figures

  • Figure 4-1: Global - Microfluidics Market (Billion US$), 2017-2022
  • Figure 4-2: Share of Healthcare in Global Microfluidics Market (%), 2017 & 2022
  • Figure 4-3: Global - Healthcare Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-1: Global - Microfluidics Market by Material (%), 2017
  • Figure 6-2: Global - Microfluidics Market for Ceramics (Billion US$), 2017-2022
  • Figure 6-3: Global - Microfluidics Market for Polymers (Billion US$), 2017-2022
  • Figure 6-4: Global - Microfluidics Market for Others (Billion US$), 2017-2022
  • Figure 6-5: Global- Microfluidics Market by Components (%), 2017
  • Figure 6-6: Global - Microfluidics Chip Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-7: Global - Microfluidics Pumps Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-8: Global - Microfluidics Needles Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-9: Global - Other Microfluidic Components Market (Billion US$), 2017-2022
  • Figure 6-10: Global- Microfluidics Market by Applications (%), 2017
  • Figure 6-11: Global - Microfluidics Market for In-Vitro Diagnostics (Billion US$), 2017-2022
  • Figure 6-12: Global - Microfluidics Market for Pharmaceutical & Life Sciences Research (Billion US$), 2017-2022
  • Figure 6-13: Global - Microfluidics Market for Drug Delivery (Billion US$), 2017-2022
  • Figure 6-14: Global - Microfluidics Market for Other Applications (Billion US$), 2017-2022
  • Figure 6-15: Global - Microfluidics Market by Geography (%), 2017
  • Figure 6-16: North America - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-17: Europe - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-18: Asia Pacific - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-19: RoW - Microfluidics Market (Billion US$), 2017-2022
  • Figure 9-1: Fluidigm Corporation - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-2: Fluidigm Corporation - Revenue Breakup by Geography (%), 2017
  • Figure 9-3: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-4: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Geography (%), 2017
  • Figure 9-5: Bio-Rad Laboratories, Inc. - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-6: Bio-Rad Laboratories, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-7: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2017
  • Figure 9-8: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-9: Agilent Technologies, Inc. - Revenue Breakup by Segments (%), 2017
  • Figure 9-10: Agilent Technologies, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-11: Perkin Elmer, Inc. - Revenue Breakup by Business Segments (%), 2017
  • Figure 9-12: Perkin Elmer, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-13: Illumina, Inc. - Net Sales Break up by Business Segments (%), 2017
  • Figure 9-14: Illumina, Inc. - Net Sales Break up by Geography (%), 2017
  • Figure 9-15: Shimadzu Corporation - Net Sales Break up by Business Segments (%), 2017
  • Figure 9-16: Shimadzu Corporation - Net Sales Break up by Geography (%), 2017
  • Figure 9-17: Danaher Corporation - Revenue by Segment (%), 2017
  • Figure 9-18: Danaher Corporation - Revenue by Geography (%), 2017
  • Figure 9-19: Abbott - Revenue by Segment (%), 2017
  • Figure 9-20: Abbott - Revenue by Geography (%), 2017

List of Tables

  • Table 5-1: Cost Involved in Microfluidics Chips
  • Table 6-1: Global - Cancer Incidences (Million), 2015 & 2025
  • Table 6-2: North America - Cancer Incidences (Million), 2015 & 2025
  • Table 6-3: Europe - Cancer Incidences (Million), 2015 & 2025
  • Table 6-4: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
  • Table 6-5: Rest of the World - Cancer Incidences (Million), 2015 & 2025
  • Table 8-1: List of Grants Announced for Microfluidics Research (2014-2016)
  • Table 9-1: Fluidigm Corporation - Company Financials (Billion US$), 2015-2017
  • Table 9-2: F. Hoffmann-La Roche Ltd. - Company Financials (Billion US$), 2015-2017
  • Table 9-3: Bio-Rad Laboratories, Inc. - Company Financials (Billion US$), 2015-2017
  • Table 9-4: Thermo Fisher Scientific, Inc. - Key Financials (Million US$), 2015-2017
  • Table 9-5: Agilent Technologies, Inc. - Key Financials (Million US$), 2015-2017
  • Table 9-6: Perkin Elmer, Inc. - Company Financials (Million US$), 2015-2017
  • Table 9-7: Illumina, Inc. - Net Sales (Million US$), 2015-2017
  • Table 9-8: Shimadzu Corporation - Net Sales (Million US$), 2015-2017
  • Table 9-9: Danaher Corporation - Net Sales (Million US$), 2015-2017
  • Table 9-10: Abbott - Net Sales (Million US$), 2015-2017
Back to Top
전화 문의
이용안내
 
BCC Research